Alexander K Song1,2, Kilian Hett1, Jarrod J. Eisma1, Colin D. Mcknight3, Jason Elenberger1, Adam J. Stark1, Hakmook Kang4,5, Ciaran M. Considine1, Manus J. Donahue1, and Daniel O. Claassen1
1Neurology, Vanderbilt University Medical Center, Nashville, TN, United States, 2Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN, United States, 3Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN, United States, 4Biostatistics, Vanderbilt University Medical Center, Nashville, TN, United States, 5Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, TN, United States
Synopsis
Keywords: Neurofluids, Alzheimer's Disease
A
pathological hallmark of Alzheimer’s disease (AD) is the elevated aggregation
of protein amyloid-β (Aβ) in the cerebrum.
Recent studies have suggested a role for the parasagittal dural (PSD) space in
cerebrospinal fluid (CSF) egress and associated protein clearance. A fully
connected neural network was used to generate PSD segmentation masks from 3D T
2-weighted
turbo-spin-echo data to assess the relationship between PSD space volume and Aβ burden estimated by
11C-Pittsburgh
Compound B in AD participants. PSD space hypertrophy was significantly
associated with elevated Aβ levels and was
localized to the frontal and parietal subsegments of the PSD.
Introduction
The
overall goal of this work is to apply novel MRI methods to explore surrogate
measures of cerebrospinal fluid (CSF) egress in the context of amyloid-β (Aβ) retention in
Alzheimer’s disease (AD). The amyloid hypothesis
proposes that the imbalance of Aβ production and clearance contributes
to the development of AD. Studies have
demonstrated that production rates of Aβ do
not differ in AD1, and rather, it
may be insufficient clearance of Aβ that predominately contributes to aggregation.
Increasing evidence suggests that CSF clears central
nervous waste products including Aβ via the bulk
and possibly recently-proposed glymphatic system2. CSF egress from the subarachnoid space
has been proposed partly to occur along the parasagittal dural (PSD) space
which is located along the sagittal sinus2–4. As such, changes in PSD space morphology
may have relevance to reduced clearance of Aβ
in adults with AD. To elucidate this relationship, we measured Aβ accumulation using PET with 11C-Pittsburgh
Compound B (PIB) in combination with a novel MR method for estimating PSD space
volume to test the primary hypothesis that PSD hypertrophy scales with elevated
global Aβ burden. Additionally, we visualize
the topography of the hypothesized PSD hypertrophy to understand whether
specific portions of the PSD may associate most closely with Aβ burden.Methods
All
participants had a
clinical diagnosis of AD or amnestic mild-cognitive-impairment with Aβ-positivity and were recruited from behavioral and cognitive neurology clinics and provided
written, informed consent. Acquisition. MRI
data were acquired at 3.0 Tesla (Philips) using a body coil radiofrequency
transmission and phased array 32-channel reception. The scanning protocol
consisted of a 3D T1-weighted
magnetization-prepared-rapid-gradient-echo (TR=8.1 ms, TE=3.7 ms, spatial
resolution=1.0x1.0x1.0 mm3) for anatomical reference and a 3D T2-weighted
volume isotropic-turbo-spin-echo-acquisition (TR=2500 ms, TE=331 ms, spatial
resolution=0.78x0.78x0.78 mm3) for PSD space volumetric measurement.
PET data were acquired using a Digital PET/CT scanner (Philips Vereos) with
three-dimensional emission acquisition. Following an intravenous bolus
injection of 11C-PIB, a 70-minute dynamic PET scan was acquired and
reconstructed with a direct Fourier method with Fourier reprojection (spatial
resolution=2.0x2.0x2.0 mm3) algorithm. Analysis. PSD
segmentations were generated from 3D T2-weighted TSE images with a
combination of a fully connected neural network based on a stacked U-net
architecture5. The first layer estimates a binary mask
of the peri-sinus space, and the second layer estimates a label map of the PSD
and superior sinus lumen based on T2-weighted signal intensities.
The PSD was further segmented into prefrontal, frontal, parietal and occipital
subsections. The prefrontal and frontal PSD are distinguished by a plane
crossing the pituitary gland and rostrum of the corpus callosum such that
the prefrontal PSD lies ventral to the plane and the frontal PSD dorsal. The
parietal region is delineated from the frontal PSD by the central sulcus and
extends to the parietal-occipital fissure. Finally, the occipital PSD is
delineated from the parietal-occipital fissure to the posterior end of the PSD.
All PSD volumes are expressed in cubic centimeters (cm3). T1-weighted
data were used to segment region-of-interest masks from the AssemblyNet
algorithm6. 11C-PIB PET data were used
to generate parametric binding potential (BPND) maps from a two-step
simplified reference tissue model (SRTM2)7, using cerebellar gray matter as a
reference region, in PMOD (version 4.2, PMOD Technologies LLC, Zürich,
Switzerland). Parametric BPND maps were transformed to native T1-weighted
space and a region-based voxel-wise partial volume correction was applied8. Global Aβ
burden was estimated from a mask of commonly observed Aβ
aggregation topography9. Statistical testing. To test
the primary hypothesis that PSD hypertrophies with increasing Aβ burden, a linear regression model was defined
with 11C-PIB BPND as the dependent variable, PSD volume
as the independent variable, and age and biological sex as explanatory
variables. Additional analyses of the subsections of the PSD used a similar
linear model with PSD subsection volume as the independent variable.Results
Table 1 summarizes the demographics and
imaging outcomes for the 23 participants in the study. The linear model
assessing the primary hypothesis revealed a significant, positive relationship
between total PSD volume and global BPND (R2=0.349, p=0.017;
Figure 1). Specifically, increases in total PSD volume were closely
associated with increases in global BPND of 11C-PIB. A
schematic of the PSD subregions and associated scatterplots for each subregion
is depicted in Figure 2. Both the frontal and parietal PSD volumes were
positively associated with global BPND of 11C-PIB and met
significant criteria (frontal: R2=0.395, p=0.008; parietal: R2=0.373,
p=0.014).Discussion
We
evaluated how parasagittal dural space volume as estimated on 3D, high spatial
resolution T2-weighted MRI relates to global Aβ burden in adults with varying levels of disease
burden. Analyses revealed that hypertrophy of the total PSD space is associated
with elevations in global Aβ burden
specifically in the frontal and parietal subsegments. These findings suggest
that CSF egress within these segments of the PSD may play a relevant role in
the clearance of Aβ aggregates. This finding
is particularly intriguing given that the strongest relationships are seen in
subsegments correlated with commonly observed Aβ
aggregation topography.Conclusion
Frontal
and parietal parasagittal dural spaces, quantified from recently-validated deep
learning algorithms applied to submillimeter 3D T2-weighted
MRI, were significantly larger in Alzheimer’s disease patients with elevated
levels of Aβ burden.Acknowledgements
No acknowledgement found.References
1. Mawuenyega KG, Sigurdson W, Ovod V, et al. Decreased
Clearance of CNS β-Amyloid in Alzheimer’s Disease. Science (1979).
2010;330(6012):1774-1774.
doi:10.1126/science.1197623
2. Eide PK, Ringstad G. Cerebrospinal fluid egress to human
parasagittal dura and the impact of sleep deprivation. Brain Res.
2021;1772:147669. doi:10.1016/j.brainres.2021.147669
3. Iliff JJ, Chen MJ, Plog BA, et al. Impairment of Glymphatic
Pathway Function Promotes Tau Pathology after Traumatic Brain Injury. The
Journal of Neuroscience. 2014;34(49):16180-16193.
doi:10.1523/JNEUROSCI.3020-14.2014
4. Ringstad G, Eide PK. Cerebrospinal fluid tracer efflux to
parasagittal dura in humans. Nat Commun. 2020;11(1):354.
doi:10.1038/s41467-019-14195-x
5. Hett K, McKnight CD, Eisma JJ, et al. Parasagittal dural
space and cerebrospinal fluid (CSF) flow across the lifespan in healthy adults.
Fluids Barriers CNS. 2022;19(1):24. doi:10.1186/s12987-022-00320-4
6. Coupé P, Mansencal B, Clément M, et al. AssemblyNet: A large
ensemble of CNNs for 3D whole brain MRI segmentation. Neuroimage.
2020;219:117026. doi:10.1016/j.neuroimage.2020.117026
7. Wu Y, Carson RE. Noise Reduction in the Simplified Reference
Tissue Model for Neuroreceptor Functional Imaging. Journal of Cerebral Blood
Flow & Metabolism. 2002;22(12):1440-1452.
doi:10.1097/01.WCB.0000033967.83623.34
8. Thomas BA, Erlandsson K, Modat M, et al. The importance of
appropriate partial volume correction for PET quantification in Alzheimer’s
disease. Eur J Nucl Med Mol Imaging. 2011;38(6):1104-1119.
doi:10.1007/s00259-011-1745-9
9. Klunk WE, Koeppe RA, Price JC, et al. The Centiloid Project:
Standardizing quantitative amyloid plaque estimation by PET. Alzheimer’s
& Dementia. 2015;11(1):1. doi:10.1016/j.jalz.2014.07.003